Innovative treatments of your cardiac arrhythmia

People with atrial fibrillation (AFib) have a five times greater risk of stroke—and stroke that is related to AFib is often more disabling and fatal. Our goal is to help reduce your risk of stroke and sudden cardiac death with a range of treatment options that includes medication therapy, radiofrequency ablation, cryoablation and implantable devices with remote monitoring.

For our patients with heart rhythm disorders such as atrial fibrillation and ventricular tachycardia, our experienced team of electrophysiologists, cardiac surgeons and advanced practitioners will work together to develop a treatment plan just for you by applying the most innovative and least invasive techniques and procedures available.

Nearly 95 percent of our patients have their leads removed without the need for open-heart surgery.

Why choose Lankenau Heart Institute for cardiac arrhythmia care

Conveniently located just outside of Philadelphia, Lankenau heart Institute has a highly specialized cardiac arrhythmia team known worldwide for their experience in the diagnosis and treatment of heart rhythm disorders.

Here are a few more reasons to let us care for your heart:

  • Access to breakthrough technologies and treatments. Our clinicians have been involved in research resulting in FDA-approved blood-thinning medications to reduce stroke risk. We also have expertise in implanting newly approved left atrial appendage closure (LAAC) devices (WATCHMAN), which prevent movement of blood clots that can cause stroke in patients with atrial fibrillation.
  • Device implant experience – volumes. We are a high-volume center with vast experience implanting pacemakers and ICDs (implantable cardioverter defibrillator), including the leadless Micra Transcatheter Pacing System and the MRI-safe cardiac resynchronization therapy defibrillator (CRT-Ds).
  • Remote monitoring – a watchful eye on your heart at all times. Short- and long-term monitoring of your arrhythmia device allows us to diagnose and monitor your condition, and act quickly if needed.
  • Expertise in catheter ablation. This minimally-invasive treatment for ventricular tachycardia allows our surgeons to send energy to the exact region of your heart where irregular heartbeats originate and to destroy tissue that may cause irregularity.
  • Ability to identify inherited heart rhythm disorders. Our experts have experience diagnosing hereditary arrhythmias such as long QT syndrome and Brugada syndrome. Diagnosis involves a complexity of testing and skilled interpretation of the results to help us understand what’s causing your arrhythmia—and how the genetic trait may affect other family members.
  • Specialists in removing pacemakers and leads. Removing pacemakers and defibrillator leads is a complex procedure performed by our skilled specialists with surgical support on hand. Nearly 95 percent of our patients have their leads removed without the need for open-heart surgery.

Lankenau Heart Institute at Paoli Hospital is the first hospital in the Philadelphia region to implant the first CRT-Ds that are FDA-approved as safe for use with magnetic resonance imaging (MRI). Now patients in the US who receive these devices, which help treat heart failure and reduce risk of sudden cardiac arrest, can receive MRI scans if and when they need them.

Cardiovascular clinical trials at Main Line Health

Main Line Health uses clinical trials to help prevent, diagnose and treat the full range of heart and vascular conditions. Learn more about the cardiovascular clinical trials currently being offered by our renowned cardiologists and heart and vascular surgeons.

To schedule an appointment with a Lankenau Heart Institute specialist, call 1.866.CALL.MLH (225.5654) or use our secure online appointment request form.